News | RIVM

Launch of the European project RISK-HUNT3R

The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.

Effects of COVID-19 vaccination becoming increasingly visible

In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.

People born in 1981 invited for COVID-19 vaccination

As of today, people born in 1981 can schedule an appointment online via www.coronavaccinatie-afspraak.nl for vaccination by the Municipal Public Health Services (GGDs).

Screening for chronic Q-fever is only cost-effective for specific groups

RIVM has investigated for which groups screening for chronic Q-fever might be cost-effective.

Pneumococcal disease in the elderly

The Health Council of the Netherlands is preparing an advice on pneumococcal vaccination for the elderly on request of the Ministry of Health, Welfare and Sport.

Statement on health care spending Down syndrome

Recently a tweet containing a video from a Dutch tv-show about Down syndrome caused a lot of turmoil on Twitter.

Temporary dermal fillers prove harmless

RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.

Slight increase of the number of tuberculosis patients in 2016

For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.

Promising biobased alternatives to controversial polar aprotic solvents

There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .